{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T01:01:22Z","timestamp":1770339682029,"version":"3.49.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the 2020 Annual Medical Research Project of Jiangsu Commission of Health","award":["ZDA 2020014"],"award-info":[{"award-number":["ZDA 2020014"]}]},{"name":"Medical Science and Technology Development Foundation, Nanjing Department of Health","award":["ZKX 22040"],"award-info":[{"award-number":["ZKX 22040"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,30]]},"abstract":"<jats:p>To investigate the prevalence of liver injury and the factors influencing severe liver injury in antiretroviral therapy (ART)-na\u00efve patients with human immunodeficiency virus (HIV) infection. ART-na\u00efve HIV-1 infected patients who visited the outpatient department of the Infection Department of the Second Hospital of Nanjing between January 1, 2005, and May 31, 2022, were included in the study. The clinical data of patients with baseline liver injury were retrospectively collected. Liver injury was classified as grade 1, 2, 3, or 4 according to the severity scale of adverse events in adults and children with acquired immunodeficiency syndrome (AIDS), based on the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total bilirubin (TBIL). A total of 982 patients were included in the analysis. The overall prevalence of liver injury (grades 1\u20134) was 19.3% (982\/5099), with grade 1 liver injury (75.9%, 745\/982) be the most common. Multivariate logistic regression analysis revealed that high-density lipoprotein cholesterol (HDL-C) was a protective factor against severe liver injury (odds ratio [OR]\u2005=\u20050.28, 95% CI\u2005=\u20050.08\u20130.99, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.048). Conversely, hepatitis B virus (HBV) infection (OR\u2005=\u20054.02, 95% CI\u2005=\u20051.82\u20138.88, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.001) elevated gamma-glutamyl transpeptidase (GGT, OR\u2005=\u20051.04, 95% CI\u2005=\u20051.01\u20131.06, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.004), and elevated levels of lactic dehydrogenase (LDH, OR\u2005=\u20051.03, 95% CI\u2005=\u20051.01\u20131.04, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.002) were identified as independent risk factors for severe liver injury in newly treated HIV\/AIDS patients. Liver injury is prevalent among HIV\/AIDS patients who have not initiated ART. HDL-C, HBV infection, GGT, and LDH are significant factors influencing the severity of liver injury.<\/jats:p>","DOI":"10.1097\/md.0000000000041261","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T20:02:27Z","timestamp":1749758547000},"page":"e41261","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and influencing factors of liver injury in na\u00efve patients with HIV\/AIDS in Nanjing from 2005 to 2022: Cross-sectional study"],"prefix":"10.1097","volume":"104","author":[{"given":"Nawei","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyun","family":"Di","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihao","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingli","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingli","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The School of Public Health of Nanjing Medical University, The Second Hospital of Nanjing, Nanjing, Jiangsu Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengqing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The School of Public Health of Nanjing Medical University, The Second Hospital of Nanjing, Nanjing, Jiangsu Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjing","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The School of Public Health of Nanjing Medical University, The Second Hospital of Nanjing, Nanjing, Jiangsu Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rentian","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5942-0600","authenticated-orcid":false,"given":"Hongxia","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"},{"name":"Department of Infectious Disease, The School of Public Health of Nanjing Medical University, The Second Hospital of Nanjing, Nanjing, Jiangsu Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250612","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S2352-3018(23)00028-0","article-title":"Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies.","volume":"10","author":"Trickey","year":"2023","journal-title":"Lancet HIV"},{"key":"R3-20250612","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41575-018-0085-7","article-title":"HIV and the liver.","volume":"16","author":"Chamroonkul","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R4-20250612","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/v11030200","article-title":"Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART.","volume":"11","author":"Zicari","year":"2019","journal-title":"Viruses"},{"key":"R5-20250612","first-page":"632","article-title":"Incidence and influencing factors of AIDS-related and non-AIDS-related deaths after receiving antiretroviral therapy among HIV-positive individuals in Dehong Dai and Jingpo Autonomous Prefecture, 2010-2019.","volume":"42","author":"Yao","year":"2021","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"R6-20250612","first-page":"87","article-title":"HIV and liver disease.","volume":"25","author":"Navarro","year":"2022","journal-title":"AIDS Rev"},{"key":"R7-20250612","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cgh.2023.01.001","article-title":"Prevalence and characteristics of nonalcoholic fatty liver disease and fibrosis in people living with HIV monoinfection: a systematic review and meta-analysis.","volume":"21","author":"Kalligeros","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R8-20250612","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S2468-2667(16)30020-2","article-title":"Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort.","volume":"2","author":"Croxford","year":"2017","journal-title":"Lancet Public Health"},{"key":"R9-20250612","doi-asserted-by":"crossref","first-page":"817370","DOI":"10.3389\/fmed.2022.817370","article-title":"The correlated risk factors for severe liver damage among HIV-positive inpatients with abnormal liver tests.","volume":"9","author":"Liu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R10-20250612","doi-asserted-by":"crossref","first-page":"9631731","DOI":"10.1155\/2020\/9631731","article-title":"Abnormal levels of liver enzymes and hepatotoxicity in HIV-positive, TB, and HIV\/TB-coinfected patients on treatment in Fako Division, Southwest Region of Cameroon.","volume":"2020","author":"Enoh","year":"2020","journal-title":"Biomed Res Int"},{"key":"R11-20250612","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1186\/s12879-022-07838-w","article-title":"Prevalence of hepatotoxicity among HIV-infected patients in Ethiopia: a systematic review and meta-analysis.","volume":"22","author":"Mohammed","year":"2022","journal-title":"BMC Infect Dis"},{"key":"R12-20250612","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/QAD.0000000000002233","article-title":"Clinical significance of elevated liver transaminases in HIV-infected patients.","volume":"33","author":"Cai","year":"2019","journal-title":"AIDS"},{"key":"R13-20250612","doi-asserted-by":"crossref","first-page":"e023140","DOI":"10.1136\/bmjopen-2018-023140","article-title":"Liver damage in patients living with HIV on antiretroviral treatment with normal baseline liver function and without HBV\/HCV infection: an 11-year retrospective cohort study in Guangxi, China.","volume":"9","author":"Qin","year":"2019","journal-title":"BMJ Open"},{"key":"R14-20250612","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3748\/wjg.v25.i4.398","article-title":"Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression.","volume":"25","author":"Ganesan","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R15-20250612","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12879-018-3462-5","article-title":"Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy.","volume":"18","author":"Giacomelli","year":"2018","journal-title":"BMC Infect Dis"},{"key":"R16-20250612","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12876-022-02305-x","article-title":"Risk factors of severe hepatotoxicity among HIV-1 infected individuals initiated on highly active antiretroviral therapy in the Northwest Region of Cameroon.","volume":"22","author":"Abongwa","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"R17-20250612","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/labmed\/lmaa106","article-title":"Incidence of hepatotoxicity in iranian patients with HIV on antiretroviral therapies and its correlation with virologic response to HIV treatment.","volume":"52","author":"Hashempour","year":"2021","journal-title":"Lab. Med"},{"key":"R18-20250612","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1055\/a-2150-2077","article-title":"Elevated liver enzymes in a German tertiary-care hospital: distribution, diagnostic steps and diagnosis groups.","volume":"62","author":"Bock","year":"2024","journal-title":"Z Gastroenterol"},{"key":"R19-20250612","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/liv.15629","article-title":"Genetic risk of fatty liver disease and mortality in the general population: a Mendelian randomization study.","volume":"43","author":"Gellert-Kristensen","year":"2023","journal-title":"Liver Int"},{"key":"R20-20250612","doi-asserted-by":"crossref","first-page":"ofab076","DOI":"10.1093\/ofid\/ofab076","article-title":"Risk factors associated with chronic liver enzyme elevation in persons with HIV without hepatitis B or C coinfection in the combination antiretroviral therapy era.","volume":"8","author":"Wood","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"R21-20250612","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1186\/s13104-019-4748-4","article-title":"Liver enzyme elevation in patients taking HAART compared with treatment na\u00efve controls at Debre Berhan Referral Hospital: a comparative cross-sectional study, Northeast Ethiopia.","volume":"12","author":"Tesfa","year":"2019","journal-title":"BMC Res Notes"},{"key":"R22-20250612","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAD.0b013e3282f0e2fd","article-title":"Antiretroviral drugs and liver injury.","volume":"22","author":"Soriano","year":"2008","journal-title":"AIDS"},{"key":"R23-20250612","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1038\/s41598-024-57900-7","article-title":"Predictors of severe hepatotoxicity among retroviral infected adults on HAART regimen in Ilubabor Zone, Southwest Ethiopia.","volume":"14","author":"Darge","year":"2024","journal-title":"Sci Rep"},{"key":"R24-20250612","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/cid\/ciae014","article-title":"Time trends in causes of death in people with HIV: insights from the swiss HIV cohort study.","volume":"79","author":"Weber","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"R25-20250612","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/hiv.13245","article-title":"Incidence of and risk factors for liver damage in patients with HIV-1 mono-infection receiving antiretroviral therapy.","volume":"23","author":"Huang","year":"2022","journal-title":"HIV Med"},{"key":"R26-20250612","doi-asserted-by":"crossref","first-page":"20659","DOI":"10.7448\/IAS.19.1.20659","article-title":"Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study.","volume":"19","author":"Xie","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"R27-20250612","doi-asserted-by":"crossref","first-page":"853346","DOI":"10.3389\/fimmu.2022.853346","article-title":"HIV infection predisposes to increased chances of HBV infection: current understanding of the mechanisms favoring HBV infection at each clinical stage of HIV infection.","volume":"13","author":"Zaongo","year":"2022","journal-title":"Front Immunol"},{"key":"R28-20250612","doi-asserted-by":"crossref","first-page":"fmac006","DOI":"10.1093\/tropej\/fmac006","article-title":"Effect of probiotics on the frequency of CD4+ T-cells in HIV-infected children and adolescents: a systematic review and meta-analysis of randomized controlled trials.","volume":"68","author":"Sachdeva","year":"2022","journal-title":"J Trop Pediatr"},{"key":"R29-20250612","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/gutjnl-2021-324071","article-title":"Suppressor CD4(+) T cells expressing HLA-G are expanded in the peripheral blood from patients with acute decompensation of cirrhosis.","volume":"71","author":"Khamri","year":"2022","journal-title":"Gut"},{"key":"R30-20250612","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1097\/QAD.0000000000003659","article-title":"Hepatitis B viral replication markers and hepatic fibrosis in untreated chronic hepatitis B virus infection with and without HIV coinfection in Zambia.","volume":"37","author":"Muula","year":"2023","journal-title":"AIDS"},{"key":"R31-20250612","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3390\/v13071402","article-title":"Impact of HCV eradication on lipid metabolism in HIV\/HCV coinfected patients: data from ICONA and HepaICONA foundation cohort study.","volume":"13","author":"Spaziante","year":"2021","journal-title":"Viruses"},{"key":"R32-20250612","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12944-022-01668-0","article-title":"Long-term intra- and inter-individual biological variation of serum lipid of HIV-infected and uninfected men participating in the Los Angeles Multi-Center AIDS Cohort Study (MACS).","volume":"21","author":"Aziz","year":"2022","journal-title":"Lipids Health Dis"},{"key":"R33-20250612","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12981-022-00432-9","article-title":"Genetic and cytometric analyses of subcutaneous adipose tissue in patients with hemophilia and HIV-associated lipodystrophy.","volume":"19","author":"Mashiko","year":"2022","journal-title":"AIDS Res Ther"},{"key":"R34-20250612","doi-asserted-by":"crossref","first-page":"6343757","DOI":"10.1155\/2024\/6343757","article-title":"Bystander effects and profibrotic interactions in hepatic stellate cells during HIV and HCV coinfection.","volume":"2024","author":"Cevallos","year":"2024","journal-title":"J Immunol Res"},{"key":"R35-20250612","doi-asserted-by":"crossref","first-page":"831695","DOI":"10.3389\/fimmu.2022.831695","article-title":"The HCV envelope glycoprotein down-modulates NF-\u03baB signalling and associates with stimulation of the host endoplasmic reticulum stress pathway.","volume":"13","author":"McKay","year":"2022","journal-title":"Front Immunol"},{"key":"R36-20250612","doi-asserted-by":"crossref","first-page":"156347","DOI":"10.1016\/j.cyto.2023.156347","article-title":"Role of inflammasomes and cytokines in immune dysfunction of liver cirrhosis.","volume":"170","author":"Pratim Das","year":"2023","journal-title":"Cytokine"},{"key":"R37-20250612","doi-asserted-by":"crossref","first-page":"167084","DOI":"10.1016\/j.bbadis.2024.167084","article-title":"HIV and gp120-induced lipid droplets loss in hepatic stellate cells contribute to profibrotic profile.","volume":"1870","author":"L\u00f3pez","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"R38-20250612","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1021\/acsmeasuresciau.3c00045","article-title":"Advances and perspectives of responsive probes for measuring \u03b3-glutamyl transpeptidase.","volume":"4","author":"Zhang","year":"2024","journal-title":"ACS Meas Sci Au"},{"key":"R39-20250612","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/hep4.2015","article-title":"Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: data from the german hepatitis C-registry.","volume":"6","author":"Tacke","year":"2022","journal-title":"Hepatol Commun"},{"key":"R40-20250612","doi-asserted-by":"crossref","first-page":"102643","DOI":"10.1016\/j.redox.2023.102643","article-title":"Mitochondrial cholesterol: metabolism and impact on redox biology and disease.","volume":"61","author":"Goicoechea","year":"2023","journal-title":"Redox Biol"},{"key":"R41-20250612","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/cells10010174","article-title":"The impact of HIV- and ART-induced mitochondrial dysfunction in cellular senescence and aging.","volume":"10","author":"Schank","year":"2021","journal-title":"Cells"},{"key":"R42-20250612","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jnc.15703","article-title":"HIV-induced bystander cell death in astrocytes requires cell-to-cell viral transmission.","volume":"163","author":"Cevallos","year":"2022","journal-title":"J Neurochem"},{"key":"R43-20250612","doi-asserted-by":"crossref","first-page":"155832","DOI":"10.1016\/j.metabol.2024.155832","article-title":"Interleukin-6 classic and trans-signaling utilize glucose metabolism reprogramming to achieve anti- or pro-inflammatory effects.","volume":"155","author":"Xu","year":"2024","journal-title":"Metabolism"},{"key":"R44-20250612","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/infdis\/jiac475","article-title":"Proteomic analysis of hepatic fibrosis in human immunodeficiency virus-associated nonalcoholic fatty liver disease demonstrates up-regulation of immune response and tissue repair pathways.","volume":"227","author":"Fourman","year":"2023","journal-title":"J Infect Dis"},{"key":"R45-20250612","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1089\/vim.2024.0007","article-title":"Human immunodeficiency virus-human pegivirus coinfected individuals display functional mucosal-associated invariant T cells and follicular T cells irrespective of PD-1 expression.","volume":"37","author":"Vimali","year":"2024","journal-title":"Viral Immunol"},{"key":"R46-20250612","first-page":"1985452","article-title":"Liver enzymes abnormalities among highly active antiretroviral therapy experienced and HAART na\u00efve HIV-1 infected patients at Debre Tabor Hospital, North West Ethiopia: a comparative cross-sectional study.","volume":"2016","author":"Shiferaw","year":"2016","journal-title":"AIDS Res Treat"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T20:02:34Z","timestamp":1749758554000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":45,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041261","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}